[go: up one dir, main page]

BR0318588A - uso da vinpocetina para prevenir as complicações, particularmente as relacionadas à audição, que acompanham a epilepsia e seu tratamento - Google Patents

uso da vinpocetina para prevenir as complicações, particularmente as relacionadas à audição, que acompanham a epilepsia e seu tratamento

Info

Publication number
BR0318588A
BR0318588A BRPI0318588-5A BR0318588A BR0318588A BR 0318588 A BR0318588 A BR 0318588A BR 0318588 A BR0318588 A BR 0318588A BR 0318588 A BR0318588 A BR 0318588A
Authority
BR
Brazil
Prior art keywords
vinpocetin
epilepsy
accompany
treatment
hearing
Prior art date
Application number
BRPI0318588-5A
Other languages
English (en)
Inventor
Maria Stiges Berrondo
Vladimir Nekrassov Protasova
Original Assignee
Univ Mexico Nacional Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mexico Nacional Autonoma filed Critical Univ Mexico Nacional Autonoma
Publication of BR0318588A publication Critical patent/BR0318588A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"USO DA VINPOCETINA PARA PREVENIR AS COMPLICAçõES, PARTICULARMENTE AS RELACIONADAS à AUDIçãO, QUE ACOMPANHAM A EPILEPSIA E SEU TRATAMENTO". A presente invenção se relaciona com o uso da vinpocetina e os derivados destes que possam desenvolver-se e que mantenham os mesmos efeitos para o tratamento da epilepsia e suas complicações. Nossos resultados mostram que a vinpocetina inibe todas as alterações nas ondas no período que acompanham a atividade epilética cortical durante os períodos ictal e post-ictal em dois modelos experimentais de epilepsia em vivo, que a vinpocetina também inibe a marcada perda da audição e as mudanças características no EEG que induzem dois agentes convulsivos que diferem em seus mecanismos de ação. Estes achados indicam que a capacidade da vinpocetina como droga antiepiléptica não se vê acompanhada de efeitos secundários adversos.
BRPI0318588-5A 2003-10-28 2003-10-28 uso da vinpocetina para prevenir as complicações, particularmente as relacionadas à audição, que acompanham a epilepsia e seu tratamento BR0318588A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2003/000089 WO2005039482A2 (es) 2003-10-28 2003-10-28 Uso de la vinpocetina para prevenir las complicaciones, particularmente las relacionadas con la audición, que acompañan a la epilepsia y su tratamiento

Publications (1)

Publication Number Publication Date
BR0318588A true BR0318588A (pt) 2006-10-17

Family

ID=34511293

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0318588-5A BR0318588A (pt) 2003-10-28 2003-10-28 uso da vinpocetina para prevenir as complicações, particularmente as relacionadas à audição, que acompanham a epilepsia e seu tratamento

Country Status (10)

Country Link
US (1) US20070135470A1 (pt)
EP (1) EP1679059A4 (pt)
JP (1) JP2007521241A (pt)
CN (1) CN100500146C (pt)
AU (1) AU2003274807A1 (pt)
BR (1) BR0318588A (pt)
CA (1) CA2544035C (pt)
MX (1) MXPA06004690A (pt)
NZ (1) NZ547508A (pt)
WO (1) WO2005039482A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008101220A2 (en) * 2007-02-15 2008-08-21 The Board Of Trustees Of The University Of Illinois Non-invasive, bedside intra-cranial pressure monitoring system utilizing early on-set auditory evoked responses
UA121882C2 (uk) * 2015-02-04 2020-08-10 Харбін Фармасьютікал Груп Ко., Лтд. Дженерал Фармасьютікал Фекторі Діазабензофторантренові сполуки
MX2018002786A (es) * 2015-09-03 2018-12-17 Neolpharma Inc Composicion farmaceutica de vinpocetina.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201674B (en) * 1987-08-26 1990-12-28 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition suitable for curing autoimmune-type leukoencephalomyelitic diseases e.g. sclerosis multiplex
US5965568A (en) * 1995-02-15 1999-10-12 Takeda Chemical Industries, Ltd. Composition for inhibiting production or secretion of amyloid β protein to treat Down's syndrome

Also Published As

Publication number Publication date
NZ547508A (en) 2010-04-30
CN1909782A (zh) 2007-02-07
JP2007521241A (ja) 2007-08-02
EP1679059A2 (en) 2006-07-12
AU2003274807A1 (en) 2005-05-11
HK1100348A1 (zh) 2007-09-21
EP1679059A4 (en) 2009-11-04
US20070135470A1 (en) 2007-06-14
CN100500146C (zh) 2009-06-17
MXPA06004690A (es) 2006-07-05
CA2544035C (en) 2012-01-10
CA2544035A1 (en) 2005-05-06
WO2005039482A3 (es) 2005-09-01
WO2005039482A2 (es) 2005-05-06
AU2003274807A8 (en) 2005-05-11

Similar Documents

Publication Publication Date Title
Wille et al. Chronic high‐frequency deep‐brain stimulation in progressive myoclonic epilepsy in adulthood—Report of five cases
Bauer et al. Transcutaneous vagus nerve stimulation (tVNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial (cMPsE02)
Onesti et al. H‐coil repetitive transcranial magnetic stimulation for pain relief in patients with diabetic neuropathy
Cukiert et al. Centro-median stimulation yields additional seizure frequency and attention improvement in patients previously submitted to callosotomy
Minen et al. The neuropsychiatry of tinnitus: a circuit-based approach to the causes and treatments available
Seynaeve et al. Randomized crossover sham‐controlled clinical trial of targeted low‐frequency transcranial magnetic stimulation comparing a figure‐8 and a round coil to treat refractory neocortical epilepsy
Bastin et al. Changes of oscillatory activity in the subthalamic nucleus during obsessive-compulsive disorder symptoms: two case reports
Qiu et al. Sensorimotor cortical changes assessed with resting-state fMRI following total brachial plexus root avulsion
Hilberg et al. Joint pain in people with hemophilia depends on joint status
Gerdle et al. Altered neuromuscular control mechanisms of the trapezius muscle in fibromyalgia
Nadler et al. What is a seizure focus?
Billot et al. Effect of cutaneous heat pain on corticospinal excitability of the tibialis anterior at rest and during submaximal contraction
Thabit et al. Combined central and peripheral stimulation for treatment of chronic tinnitus: a randomized pilot study
Omland et al. Modulation of visual evoked potentials by high-frequency repetitive transcranial magnetic stimulation in migraineurs
Zhang et al. Differences in Clinical Characteristics and Brain Activity Between Patients With Low‐and High‐Frequency Tinnitus
Keswani et al. Amelioration of spinal myoclonus with levetiracetam
BR0318588A (pt) uso da vinpocetina para prevenir as complicações, particularmente as relacionadas à audição, que acompanham a epilepsia e seu tratamento
Jin et al. Neurophysiological oscillatory markers of hypoalgesia in conditioned pain modulation
Grosso et al. Aicardi syndrome with favorable outcome: case report and review
Yu et al. Surgical treatment of hypermotor seizures originating from the temporal lobe
BR112022017998A2 (pt) Formulações de liberação controlada compreendendo drotaverina ou sal da mesma
Chamoun et al. Functional recovery following resection of an epileptogenic focus in the motor hand area
Purohit The effects of vestibular implants and other existing treatment options of individuals with bilateral vestibular hypofunction: a review
Paiement et al. Functional reorganization of the human auditory pathways following hemispherectomy: an fMRI demonstration
Carey Men and women really do think differently

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: REFERENTE AO DESPACHO 7.4 NOTIFICADO NA RPI 2319, DE 16/06/2015

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL